These are self-pay prices and do not take into account any discounts or prescription insurance coverage that you may have. Actual prices are calculated at the time your prescription is processed by the pharmacy.
UCB receives CHMP positive opinion on Keppra European marketing approval recommended for Keppra as adjunctive treatment of partial-onset seizures in infants and young children aged one month to under four years (Source: Pharmacy Europe)
